RD-X19

· EmitBio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RD-X19, covering 2022-09-08 to 2022-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19 [NA]